Real World Data, Biopesticides, 3D Bioprinting
In this issue:
- Real World Data: Beyond clinical trials
- Biopesticides: Next-generation antibodies expand beyond healthcare and into the world of agriculture
- Drug development: 3D bioprinted tissues are set to improve predictivity of preclinical disease models
- Bioeconomy: Lodz Declaration lays down blueprint for EU bioeconomy strategy & action plan update
- Interview with Jurgen Dressel, Novartis litigation expert on the impact of the EPO Early Certainty
Initiative - News from our partner associations European Biotechnology Network, EAPB, EDMA, DIA, BIO Deutschland and the Swiss Biotech Association
- ... and our Special BioFairs Compass.